News
A group of scientists in Japan has discovered that fermented stevia, a plant commonly used as a calorie-free sweetener, may ...
The Diffuse Large B-cell Lymphoma (DLBCL) market is witnessing significant growth, driven by advancements in targeted immunotherapies like CAR-T cell therapy and bispecific antibodies. These therapies ...
Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly ...
A hormone-free pill, known as YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite, has concluded its first safety trial in humans, getting a step closer to increasing ...
"It was a lot of treatment. Some people assume that once cancer treatment ends, everything goes back to normal but I’m still ...
A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.
While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...
The latest wave of value creators to emerge from Babraham Research Campus’ Accelerate@Babraham accelerator used skills honed ...
New long-term data from the Phase III FLAURA2 trial confirm that Tagrisso combined with chemotherapy delivers a significant overall survival benefit over monotherapy in patients with advanced ...
A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results